← FDA Drug Approvals (Drugs@FDA)
PALIPERIDONE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: LUPIN · Approved 2022-06-29
Drug application
- FDA Application #
ANDA208643- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- PALIPERIDONE
- Generic name
- Paliperidone
- Active ingredients
- PALIPERIDONE
- Dosage form
- TABLET, EXTENDED RELEASE
- Route
- ORAL
- Marketing status
- Discontinued
- Sponsor
- LUPIN
- First approval
- 2022-06-29
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown